BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24252474)

  • 1. New insights into the structure and function of the plasminogen/plasmin system.
    Law RH; Abu-Ssaydeh D; Whisstock JC
    Curr Opin Struct Biol; 2013 Dec; 23(6):836-41. PubMed ID: 24252474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Structure and functions of plasminogen/plasmin system].
    Aĭsina RB; Mukhametova LI
    Bioorg Khim; 2014; 40(6):642-57. PubMed ID: 25895360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues.
    Parry MA; Zhang XC; Bode I
    Trends Biochem Sci; 2000 Feb; 25(2):53-9. PubMed ID: 10664583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The X-ray crystal structure of full-length human plasminogen.
    Law RH; Caradoc-Davies T; Cowieson N; Horvath AJ; Quek AJ; Encarnacao JA; Steer D; Cowan A; Zhang Q; Lu BG; Pike RN; Smith AI; Coughlin PB; Whisstock JC
    Cell Rep; 2012 Mar; 1(3):185-90. PubMed ID: 22832192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human plasminogen catalytic domain undergoes an unusual conformational change upon activation.
    Wang X; Terzyan S; Tang J; Loy JA; Lin X; Zhang XC
    J Mol Biol; 2000 Jan; 295(4):903-14. PubMed ID: 10656799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen: a structural review.
    Ponting CP; Marshall JM; Cederholm-Williams SA
    Blood Coagul Fibrinolysis; 1992 Oct; 3(5):605-14. PubMed ID: 1333289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin.
    Hunt JA; Petteway SR; Scuderi P; Novokhatny V
    Thromb Haemost; 2008 Sep; 100(3):413-9. PubMed ID: 18766256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCM, a novel M-like protein from Streptococcus canis, binds (mini)-plasminogen with high affinity and facilitates bacterial transmigration.
    Fulde M; Rohde M; Hitzmann A; Preissner KT; Nitsche-Schmitz DP; Nerlich A; Chhatwal GS; Bergmann S
    Biochem J; 2011 Mar; 434(3):523-35. PubMed ID: 21210764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of plasminogen activation and plasmin activity by methylglyoxal modification of the zymogen.
    Léránt I; Kolev K; Gombás J; Machovich R
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):311-20. PubMed ID: 10899632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The solution phase interaction between apolipoprotein(a) and plasminogen inhibits the binding of plasminogen to a plasmin-modified fibrinogen surface.
    Sangrar W; Gabel BR; Boffa MB; Walker JB; Hancock MA; Marcovina SM; Horrevoets AJ; Nesheim ME; Koschinsky ML
    Biochemistry; 1997 Aug; 36(34):10353-63. PubMed ID: 9265615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of a substrate analogue can induce co-operative structure in the plasmin serine-proteinase domain.
    Teuten AJ; Cooper A; Smith RA; Dobson CM
    Biochem J; 1993 Jul; 293 ( Pt 2)(Pt 2):567-72. PubMed ID: 8343136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of substituted laminin A chain-derived peptides on the conformation and activation kinetics of plasminogen.
    Stack MS; Pizzo SV
    Arch Biochem Biophys; 1994 Feb; 309(1):117-22. PubMed ID: 8117101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of heparin on plasmin and plasminogen activation].
    Manmi S
    Nihon Ketsueki Gakkai Zasshi; 1971 Oct; 34(5):591-4. PubMed ID: 4261759
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of a reduced form of plasma plasminogen as the precursor for angiostatin formation.
    Butera D; Wind T; Lay AJ; Beck J; Castellino FJ; Hogg PJ
    J Biol Chem; 2014 Jan; 289(5):2992-3000. PubMed ID: 24338014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural and engineered plasmin inhibitors: applications and design strategies.
    Swedberg JE; Harris JM
    Chembiochem; 2012 Feb; 13(3):336-48. PubMed ID: 22238174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
    Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
    J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of histidine-rich glycoprotein (HRG) function via plasmin-mediated proteolytic cleavage.
    Poon IK; Olsson AK; Hulett MD; Parish CR
    Biochem J; 2009 Oct; 424(1):27-37. PubMed ID: 19712047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kringle domains and plasmin denaturation.
    Shi GY; Wu DH; Wu HL
    Biochem Biophys Res Commun; 1991 Jul; 178(1):360-8. PubMed ID: 1829887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasminogen and plasmin in Alzheimer's disease.
    Barker R; Love S; Kehoe PG
    Brain Res; 2010 Oct; 1355():7-15. PubMed ID: 20709033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.